Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.psy.45.3.271DOI Listing

Publication Analysis

Top Keywords

citalopram quality
4
quality life
4
life lung
4
lung transplant
4
transplant recipients
4
citalopram
1
life
1
lung
1
transplant
1
recipients
1

Similar Publications

Background: This study aims to assess the effectiveness of low-dose Escitalopram (10 mg) or low-dose Desvenlafaxine (25 mg) combined with mindfulness-based cognitive therapy (MBCT) in addressing challenges in treating generalized anxiety disorder (GAD), particularly in patients resistant to conventional therapies.

Methods: A prospective cohort study was conducted with individuals diagnosed with treatment-resistant GAD. group A included patients unresponsive to citalopram, imipramine, paroxetine, and sertraline, who were then treated with low-dose Escitalopram (10 mg) combined with MBCT.

View Article and Find Full Text PDF

Psoriasis, a chronic inflammatory skin disease, poses a significant burden on patients' quality of life and healthcare systems. While mild-to-moderate cases are treated topically, usually combined with phototherapy, severe cases require systemic treatment with immunosuppressants, retinoids or biologics. However, all available treatments have drawbacks in terms of efficiency and side effects.

View Article and Find Full Text PDF

Increased pharmaceutical usage has led to their widespread presence in aquatic environments, resulting in concerns regarding their potential environmental impacts. Antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) like citalopram, are frequently detected in European surface waters. Acute laboratory studies have demonstrated that citalopram can inhibit algal growth, immobilise Daphnia magna, and may result in foot detachment (i.

View Article and Find Full Text PDF

Unlabelled: Although evidence-based treatments for Prolonged Grief Disorder (PGD) exist, pretreatment characteristics associated with differential improvement trajectories have not been identified. To identify clinical factors relevant to optimizing PGD treatment outcomes, we used unsupervised and supervised machine learning to study treatment effects from a double-blinded, placebo-controlled, randomized clinical trial. Participants were randomized into four treatment groups for 20 weeks: citalopram with grief-informed clinical management, citalopram with prolonged grief disorder therapy (PGDT), pill placebo with PGDT, or pill placebo with clinical management.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!